C12N 2710/00062
By genetic engineering
Official title: by genetic engineering
C12N2710/00062 (By genetic engineering) appears on 0 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 0
- Published applications
- 5
- Assignees
- 4
- Inventors
- 13
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Mutant nudivirus insect control27 Nov 2025US 2025/0361493 A1University of Kentucky Research Foundation
- Mutant nudivirus insect control25 May 2023US 2023/0159900 A1University of Kentucky Research Foundation
- Method for producing human professional antigen-presenting cells9 Mar 2023US 2023/0070866 A1AGC Inc.
- Recombinant Ranavirus, Methods of Production, and Its Use as a Human Vaccine Vector31 Jan 2019US 2019/0032080 A1
- Crisprs19 Jul 2018US 2018/0201921 A1Excision Biotherapeutics, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.